Company Performance Metrics
Jonathan Schoeff: Faculty, KOL- Gianluca Iasci: Vice President of Global Sales and Strategic Growth for the European region
K2M Group Holdings, Inc. (K2M) is a global medical device company focused on designing, developing and commercializing spine technologies and techniques. Its spine products are used by spine surgeons to treat some of the most difficult and challenging spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. Its products
consist of implants, disposables and instruments which are marketed and sold primarily to hospitals for use by spine surgeons. In addition to its current product portfolio, it continue to invest in the design, development and commercialization of new solutions for unmet clinical needs in the complex spine and MIS markets by its product development process. The Company market and sell its products in the United States and 28 other countries. The Company’s products include Complex Spine, Minimally Invasive Spine and Degenerative Spine. The Company’s technologies include MESA, Rail 4D, Deformity Cricket, SERENGETI, RAVINE, EVEREST and tifix.
